Discontinuation report TEVA-OLMESARTAN

Last updated on 2020-06-11 History
Report ID 117500
Drug Identification Number 02442205
Brand name ACT OLMESARTAN
Common or Proper name OLMESARTAN 40MG FC TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) OLMESARTAN MEDOXOMIL
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100's and 30's
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-06-08
Remaining supply date 2020-06-08
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-06-11 French Compare
v1 2020-06-11 English Compare

Showing 1 to 2 of 2